Brief: Heartsciences Receives FDA Confirmation For 510(K) Clearance Pathway
Dec 5 (Reuters) - Heart Test Laboratories Inc HSCS.O :
* HEARTSCIENCES RECEIVES FDA CONFIRMATION FOR 510(K)
CLEARANCE
PATHWAY
* HEART TEST LABORATORIES INC - REMAIN ON TRACK FOR
SUBMISSION OF
MYOVISTA TO FDA IN FIRST HALF OF 2024 AND A TARGETED CLEARANCE
DURING 2024
Source text for Eikon: ID:nGNXbGHV2Q
Further company coverage: HSCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartSciences
See all newsBrief: Heartsciences Files Definitive Proxy Statement For Proposed Business Combination With Fortitude Mining
Brief: Fortitude Provides Second Quarter 2026 Financial And Operating Highlights
Brief: Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration
Brief: Heartsciences - Files Preliminary Proxy For Business Combination With Fortitude Mining Holdings
Brief: Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights™